End-of-day quote
Johannesburg S.E.
18:00:00 2024-04-25 EDT
|
5-day change
|
1st Jan Change
|
32.54
ZAR
|
+5.62%
|
|
+4.63%
|
+6.03%
|
Fiscal Period: February |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
22,190
|
18,595
|
19,254
|
29,767
|
23,265
|
27,961
|
-
|
-
|
Enterprise Value (EV)
1 |
23,832
|
21,842
|
23,190
|
33,569
|
27,952
|
31,085
|
30,338
|
29,398
|
P/E ratio
|
30.2
x
|
31.1
x
|
28.8
x
|
34.9
x
|
23.3
x
|
28.1
x
|
22
x
|
18.9
x
|
Yield
|
1.33%
|
0.59%
|
1.39%
|
1.15%
|
1.72%
|
1.41%
|
1.85%
|
2.2%
|
Capitalization / Revenue
|
1.04
x
|
0.78
x
|
0.73
x
|
0.98
x
|
0.71
x
|
0.78
x
|
0.7
x
|
0.63
x
|
EV / Revenue
|
1.11
x
|
0.91
x
|
0.88
x
|
1.1
x
|
0.86
x
|
0.86
x
|
0.76
x
|
0.67
x
|
EV / EBITDA
|
17
x
|
12
x
|
11.8
x
|
14
x
|
10.2
x
|
10.9
x
|
9.03
x
|
7.73
x
|
EV / FCF
|
-
|
24.4
x
|
32.1
x
|
-
|
-118
x
|
17.2
x
|
17.3
x
|
15.3
x
|
FCF Yield
|
-
|
4.09%
|
3.12%
|
-
|
-0.84%
|
5.82%
|
5.77%
|
6.54%
|
Price to Book
|
10.5
x
|
8.04
x
|
6.53
x
|
8.8
x
|
5.92
x
|
6.19
x
|
5.3
x
|
4.54
x
|
Nbr of stocks (in thousands)
|
860,084
|
860,084
|
859,553
|
859,829
|
860,084
|
859,269
|
-
|
-
|
Reference price
2 |
25.80
|
21.62
|
22.40
|
34.62
|
27.05
|
32.54
|
32.54
|
32.54
|
Announcement Date
|
19-05-16
|
20-05-20
|
21-05-21
|
22-05-23
|
23-05-18
|
-
|
-
|
-
|
Fiscal Period: February |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
21,420
|
23,984
|
26,278
|
30,407
|
32,664
|
36,013
|
39,889
|
44,189
|
EBITDA
1 |
1,404
|
1,824
|
1,971
|
2,394
|
2,746
|
2,851
|
3,360
|
3,803
|
EBIT
1 |
1,218
|
1,248
|
1,266
|
1,539
|
1,744
|
1,772
|
2,154
|
2,455
|
Operating Margin
|
5.69%
|
5.21%
|
4.82%
|
5.06%
|
5.34%
|
4.92%
|
5.4%
|
5.56%
|
Earnings before Tax (EBT)
1 |
1,056
|
868.8
|
940.9
|
1,227
|
1,417
|
1,428
|
1,740
|
2,002
|
Net income
1 |
734.7
|
598.2
|
668.7
|
853.4
|
1,000
|
987.9
|
1,278
|
1,476
|
Net margin
|
3.43%
|
2.49%
|
2.54%
|
2.81%
|
3.06%
|
2.74%
|
3.2%
|
3.34%
|
EPS
2 |
0.8540
|
0.6960
|
0.7780
|
0.9920
|
1.163
|
1.158
|
1.479
|
1.725
|
Free Cash Flow
1 |
-
|
893.6
|
722.9
|
-
|
-236
|
1,809
|
1,752
|
1,922
|
FCF margin
|
-
|
3.73%
|
2.75%
|
-
|
-0.72%
|
5.02%
|
4.39%
|
4.35%
|
FCF Conversion (EBITDA)
|
-
|
48.99%
|
36.68%
|
-
|
-
|
63.44%
|
52.13%
|
50.55%
|
FCF Conversion (Net income)
|
-
|
149.38%
|
108.1%
|
-
|
-
|
183.11%
|
137.1%
|
130.29%
|
Dividend per Share
2 |
0.3420
|
0.1280
|
0.3110
|
0.3970
|
0.4660
|
0.4590
|
0.6026
|
0.7165
|
Announcement Date
|
19-05-16
|
20-05-20
|
21-05-21
|
22-05-23
|
23-05-18
|
-
|
-
|
-
|
Fiscal Period: February |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2023 S1
|
---|
Net sales
|
11,848
|
12,137
|
12,807
|
13,471
|
14,936
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
388.1
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
-
|
-
|
-
|
-
|
602.5
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.3100
|
0.3860
|
0.3600
|
0.4180
|
0.4840
|
0.7000
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-11-07
|
20-05-20
|
20-11-05
|
21-05-21
|
21-11-03
|
22-09-30
|
Fiscal Period: February |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,641
|
3,247
|
3,936
|
3,802
|
4,687
|
3,124
|
2,377
|
1,437
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.169
x
|
1.78
x
|
1.997
x
|
1.588
x
|
1.707
x
|
1.096
x
|
0.7076
x
|
0.3779
x
|
Free Cash Flow
1 |
-
|
894
|
723
|
-
|
-236
|
1,809
|
1,752
|
1,923
|
ROE (net income / shareholders' equity)
|
40.1%
|
28.9%
|
25.9%
|
27.4%
|
27.7%
|
23.2%
|
25.5%
|
25.5%
|
ROA (Net income/ Total Assets)
|
-
|
5.67%
|
5.63%
|
-
|
6.76%
|
6.22%
|
7.67%
|
8.3%
|
Assets
1 |
-
|
10,554
|
11,885
|
-
|
14,796
|
15,892
|
16,663
|
17,785
|
Book Value Per Share
2 |
2.450
|
2.690
|
3.430
|
3.940
|
4.570
|
5.250
|
6.140
|
7.160
|
Cash Flow per Share
2 |
1.070
|
-
|
-
|
1.600
|
0.9900
|
1.910
|
2.590
|
3.120
|
Capex
1 |
395
|
363
|
401
|
377
|
1,090
|
971
|
907
|
928
|
Capex / Sales
|
1.84%
|
1.51%
|
1.53%
|
1.24%
|
3.34%
|
2.7%
|
2.27%
|
2.1%
|
Announcement Date
|
19-05-16
|
20-05-20
|
21-05-21
|
22-05-23
|
23-05-18
|
-
|
-
|
-
|
Last Close Price
32.54
ZAR Average target price
30
ZAR Spread / Average Target -7.81% Consensus |
1st Jan change
|
Capi.
|
---|
| +6.03% | 1.49B | | -29.67% | 10.84B | | -28.54% | 6.06B | | +8.14% | 6.04B | | -11.41% | 5.86B | | -1.17% | 4.69B | | +52.19% | 4.29B | | -12.31% | 3.61B | | -14.86% | 3.33B | | -6.93% | 3.01B |
Other Drug Retailers
|